Literature DB >> 9487456

Sputum microscopy results at two and three months predict outcome of tuberculosis treatment.

F Z Zhao1, M H Levy, S Wen.   

Abstract

OBJECTIVE: To assess the importance of monitoring sputum conversion as an early treatment indicator of treatment success.
METHODS: Retrospective analysis of sputum conversion in a cohort of 'cured' tuberculosis patients.
RESULTS: Of 65 (95%) patients whose sputum converted in the third month of treatment, 62 were cured; only 21 of 35 (60%) patients whose sputum was still positive at the end of three months of treatment were ultimately cured.
CONCLUSION: Sputum conversion during the third month of treatment is an important predictor of treatment success; failure to convert predicts treatment failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9487456

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  20 in total

1.  Application of oxidation-reduction assay for monitoring treatment of patients with pulmonary tuberculosis.

Authors:  Parissa Farnia; Foroazan Mohammadi; Mehdi Mirsaedi; Abolhasan Zia Zarife; Javad Tabatabee; Katayoon Bahadori; Muslem Bahadori; Mohammad Reza Masjedi; Ali Akbar Velayati
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

2.  Treatment outcomes of pulmonary tuberculosis in the past decade in the mainland of China: a meta-analysis.

Authors:  Xiangwei Li; Yu Yang; Jianmin Liu; Feng Zhou; Wei Cui; Ling Guan; Fei Shen; Cong Gao; Mufei Li; Qi Jin; Lei Gao
Journal:  Front Med       Date:  2013-07-11       Impact factor: 4.592

3.  Profile of tuberculosis patients with delayed sputum smear conversion in the Pacific island of Vanuatu.

Authors:  S Fanai; K Viney; L Tarivonda; C Roseveare; M Tagaro; B J Marais
Journal:  Public Health Action       Date:  2014-06-21

4.  Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.

Authors:  Christine Sekaggya-Wiltshire; Amrei von Braun; Mohammed Lamorde; Bruno Ledergerber; Allan Buzibye; Lars Henning; Joseph Musaazi; Ursula Gutteck; Paolo Denti; Miné de Kock; Alexander Jetter; Pauline Byakika-Kibwika; Nadia Eberhard; Joshua Matovu; Moses Joloba; Daniel Muller; Yukari C Manabe; Moses R Kamya; Natascia Corti; Andrew Kambugu; Barbara Castelnuovo; Jan S Fehr
Journal:  Clin Infect Dis       Date:  2018-08-16       Impact factor: 9.079

Review 5.  Multi-drug resistant childhood tuberculosis.

Authors:  Varinder Singh; Satnam Kaur
Journal:  Indian J Pediatr       Date:  2010-12-31       Impact factor: 1.967

Review 6.  Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis.

Authors:  David J Horne; Sarah E Royce; Lisa Gooze; Masahiro Narita; Philip C Hopewell; Payam Nahid; Karen R Steingart
Journal:  Lancet Infect Dis       Date:  2010-06       Impact factor: 25.071

7.  Predicting results of mycobacterial culture on sputum smear reversion after anti-tuberculous treatment: a case control study.

Authors:  Chin-Chung Shu; Jann-Tay Wang; Chih-Hsin Lee; Jann-Yuan Wang; Li-Na Lee; Chong-Jen Yu
Journal:  BMC Infect Dis       Date:  2010-03-06       Impact factor: 3.090

8.  A study of sputum conversion in new smear positive pulmonary tuberculosis cases at the monthly intervals of 1, 2 & 3 month under directly observed treatment, short course (dots) regimen.

Authors:  S Bawri; S Ali; C Phukan; B Tayal; P Baruwa
Journal:  Lung India       Date:  2008-07

9.  Smear microscopy and culture conversion rates among smear positive pulmonary tuberculosis patients by HIV status in Dar es Salaam, Tanzania.

Authors:  Mbazi Senkoro; Sayoki G Mfinanga; Odd Mørkve
Journal:  BMC Infect Dis       Date:  2010-07-16       Impact factor: 3.090

10.  Sputum completion and conversion rates after intensive phase of tuberculosis treatment: an assessment of the Rwandan control program.

Authors:  Felix R Kayigamba; Mirjam I Bakker; Veronicah Mugisha; Michel Gasana; Maarten F Schim van der Loeff
Journal:  BMC Res Notes       Date:  2012-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.